Eleftheria Sermpeti

The van also screens for lung cancer, diabetes, and other health concerns, offering "free take-home" kits that patients can use on their own.

The researchers found that older patients were "just as likely" as younger patients to have a genetic condition linked to their critical illness.

The researchers engineered a compound that kills leukemia cells with potency comparable to FDA-approved therapies by modifying these molecules.